Goldman Sachs Maintains a 'Neutral' on MAKO Surgical (MAKO); Updating Estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Dougherty & Co Downgrades MAKO Surgical (MAKO) to Neutral; Limited Upside From Current Level
August 30, 2012 8:40 AM EDTDougherty & Co downgraded MAKO Surgical (NASDAQ: MAKO) from Buy to Neutral.
Analyst, Junaid Husain, said, "With MAKO Surgical closing-in on our $18 PT, were downgrading to the NEUTRAL rating as we see the stock fully-valued at these levels. While were still... More
